CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 130 filers reported holding CABALETTA BIO INC in Q4 2023. The put-call ratio across all filers is 1.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $86,790 | +1023.1% | 11,603 | +2461.4% | 0.00% | – |
Q1 2024 | $7,728 | -87.0% | 453 | -82.7% | 0.00% | -100.0% |
Q4 2023 | $59,542 | +147.4% | 2,623 | +65.9% | 0.00% | 0.0% |
Q3 2023 | $24,063 | +128.2% | 1,581 | +93.5% | 0.00% | – |
Q2 2023 | $10,547 | +25011.9% | 817 | -83.7% | 0.00% | -100.0% |
Q1 2023 | $42 | -6.7% | 5,022 | +2.3% | 0.00% | -50.0% |
Q4 2022 | $45 | -99.6% | 4,910 | -72.0% | 0.00% | – |
Q3 2022 | $11,000 | +10.0% | 17,538 | +83.6% | 0.00% | – |
Q2 2022 | $10,000 | -73.0% | 9,554 | -48.2% | 0.00% | – |
Q1 2022 | $37,000 | +428.6% | 18,440 | +926.2% | 0.00% | – |
Q4 2021 | $7,000 | -61.1% | 1,797 | +24.6% | 0.00% | – |
Q3 2021 | $18,000 | -40.0% | 1,442 | -57.4% | 0.00% | -100.0% |
Q2 2021 | $30,000 | +66.7% | 3,385 | +113.8% | 0.00% | – |
Q1 2021 | $18,000 | -58.1% | 1,583 | -54.2% | 0.00% | -100.0% |
Q4 2020 | $43,000 | -68.6% | 3,455 | -72.7% | 0.00% | -50.0% |
Q3 2020 | $137,000 | +163.5% | 12,633 | +167.5% | 0.00% | 0.0% |
Q2 2020 | $52,000 | +136.4% | 4,722 | +59.2% | 0.00% | +100.0% |
Q1 2020 | $22,000 | -37.1% | 2,967 | +16.9% | 0.00% | -66.7% |
Q4 2019 | $35,000 | – | 2,538 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 2,825,976 | $26,140,278 | 22.61% |
VR Adviser, LLC | 1,895,285 | $17,531,386 | 2.95% |
CAXTON CORP | 84,728 | $783,735 | 2.00% |
COMMODORE CAPITAL LP | 1,010,359 | $9,346 | 1.41% |
BOONE CAPITAL MANAGEMENT LLC | 266,882 | $2,468,659 | 1.27% |
Cormorant Asset Management, LP | 1,971,739 | $18,239 | 1.22% |
TCG Crossover Management, LLC | 486,795 | $4,502,854 | 0.80% |
Boxer Capital, LLC | 540,000 | $4,995,000 | 0.26% |
Kynam Capital Management, LP | 165,486 | $1,530,746 | 0.24% |
Eversept Partners, LP | 282,874 | $2,616,585 | 0.23% |